QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 限定条件 专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Efficacy and safety of serial atorvastatin load in Chinese patients undergoing elective percutaneous coronary intervention: results of the ISCAP (Intensive Statin Therapy for Chinese Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention) randomized controlled trial 期刊论文 EUROPEAN HEART JOURNAL SUPPLEMENTS, 2015, 卷号: 17, 期号: B 作者:  Zheng, Bo;  Jiang, Jie;  Liu, Huiliang;  Zhang, Jun;  Li, Hui 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/19 Atorvastatin  Percutaneous coronary intervention  Periprocedural myocardial infarction   Nine-month angiographic and two-year clinical follow-up of polymer-free sirolimus-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease: the Nano randomized trial 期刊论文 CHINESE MEDICAL JOURNAL, 2014, 卷号: 127, 期号: 11 作者:  Zhang Yaojun;  Chen Fang;  Muramatsu, Takashi;  Xu Bo;  Li Zhanquan 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 Nano stent  polymer-free  sirolimus-eluting stent  clinical outcomes  late lumen loss   Efficacy and safety of Firebird sirolimus-eluting stent in treatment of complex coronary lesions in Chinese patients: one-year clinical and eight-month angiographic outcomes from the FIREMAN. registry 期刊论文 中华医学杂志, 2011, 卷号: 124, 期号: 6 作者:  Li Yan;  Li Chengxiang;  Wang Haichang;  Xu Bo;  Fang Weiyi 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 coronary artery disease  sirolimus-eluting stent  off-label use  clinical outcomes